mortality/aging
|
• no fetuses observed between E7.5 and E9.5
|
|
hm1
|
Urodtm1Kush/Urodtm1Kush
involves: 129S1/Sv * 129X1/SvJ |
|
|||||||||||||||||
|
• no fetuses observed between E7.5 and E9.5
|
|
ht2
|
Urodtm1Kush/Urod+
involves: 129S1/Sv * 129X1/SvJ |
|
|||||||||||||||||
|
• hepatic iron concentrations did not differ from those of wild-type mice through 1 year of age, though treatment with iron dextran elicited a significantly higher increase in hepatic iron in mutant mice than in wild-type mice
• urinary porphyrin concentrations did not differ from those of wild-type mice prior to treatment with delta-aminolevulinic acid (ALA), though treatment with either ALA alone or with both ALA and iron elicited significantly higher increases in porphyrin concentrations than in mutant mice than in wild-type mice
|
|
cx3
|
Hfetm2Nca/Hfetm2Nca Urodtm1Kush/Urod+ involves: C57BL/6J |
|
|||||||||||||||||
|
• increased urinary porphyrin concentration (hepatic levels were also increased)
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Porphyria Cutanea Tarda | 176100 | J:66704 | |